Retrospective Cohort Study
Copyright ©The Author(s) 2021.
World J Hepatol. Nov 27, 2021; 13(11): 1777-1790
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1777
Table 4 Multivariate regression analysis of outcomes for patients hospitalized for Clostridioides difficile infection with coexisting nonalcoholic fatty liver disease vs alcoholic liver disease
Outcomes
CDI with NAFLD
CDI with ALD
Unadjusted ratio (95%CI)
P value
Adjusted ratio1 (95%CI)
P value
n (weighted)
7239
5938
Hospital mortality59 (0.8%)159 (2.7%)3.34 (2.48, 4.52)< 0.00012.63 (1.25, 5.51)0.0107
Acute kidney injury938 (13%)935 (15.8%)1.26 (1.14, 1.39)< 0.00011.2 (0.93, 1.54)0.15
Respiratory failure192 (2.7%)249 (4.2%)1.61 (1.33, 1.94)< 0.00011.72 (1.09, 2.72)0.0201
Septic shock39 (0.5%)79 (1.3%)2.48 (1.69, 3.64)< 0.00012.14 (0.84, 5.46)0.109
Intestinal perforation-0 (0%)NANANANA
Intestinal obstruction331 (4.6%)133 (2.2%)0.48 (0.39, 0.59)< 0.00010.45 (0.28, 0.72)0.0010
Peritonitis61 (0.8%)69 (1.2%)1.38 (0.97, 1.95)0.0710.54 (0.25, 1.18)0.12
Colectomy45 (0.6%)15 (0.3%)0.42 (0.23, 0.74)0.0030.44 (0.14, 1.39)0.16
Ileostomy--0.65 (0.23, 1.85)0.420.99 (0.15, 6.61)0.98
LOS (days)5.75 ± 0.166.84 ± 0.231.14 (1.08, 1.21)< 0.00011.18 (1.1, 1.25)< 0.0001
Totalhospitalizationcharges (dollars)38150.34 ± 1757.0144641.74 ± 1660.661.14 (1.07, 1.22)< 0.00011.17 (1.09, 1.26)< 0.0001